RNU6-494P

Across TCGA pan-cancer cohorts, RNU6-494P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-494P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-494P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-494P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

ACC, THYM, and OV are the cancer types where RNU6-494P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.010	0.458	<.001	63	view →
THYM	OS	Tertile	All	0.289	0.891	<.001	48	view →
OV	DFS	Median	II,III,IV	0.338	0.418	.017	32	view →
KIRP	OS	Tertile	III,IV	0.209	0.729	.023	21	view →
LIHC	DFS	Tertile	All	0.271	0.558	.004	18	view →
THCA	OS	Tertile	IV	0.520	0.857	.015	12	view →
COAD	DFS	Tertile	IV	0.117	0.515	.021	9	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	9	view →
STAD	OS	Tertile	II,III,IV	0.568	0.302	.024	7	view →
SKCM	DFS	Tertile	All	0.417	0.760	.024	6	view →
READ	DFS	Tertile	II,III,IV	0.479	0.809	.043	3	view →
LAML	DFS	Median	All	0.482	0.652	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-494P–ACC (DFS)

Open the ACC breakdown →